Marble Bar Asset Management »

BioCryst Pharmaceuticals shares owned by Marble Bar Asset Management

Quarter-by-quarter ownership of BioCryst Pharmaceuticals (BCRX) shares owned by Marble Bar Asset Management from 13F filings

Historical chart of Marble Bar Asset Management investment in BioCryst Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including BioCryst Pharmaceuticals held by Marble Bar Asset Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in BioCryst Pharmaceuticals by Marble Bar Asset Management

Quarter filed Position value Share count Share price at filing
2026-03-31 $899k 94k 9.52

More positions owned by Marble Bar Asset Management

Norfolk Southern (NSC)
Commscope Hldg (VISN)
Warner Bros Discovery Com Ser A (WBD)
News Corp CL B (NWS)
Echostar Corp Cl A (SATS)
Liberty Media Corp Del Com Lbty One S A (FWONA)
Brightstar Lottery Shs Usd (BRSL)
Anterix Inc. Atex (ATEX)
Atrium Therapeutics (RNA)
Hologic
Elme Communities Sh Ben Int (ELME)
Lands' End (LE)
Priority Technology Hldgs In (PRTH)
Theravance Biopharma (TBPH)
Electronic Arts (EA)

View all positions for Marble Bar Asset Management

Top funds holding BioCryst Pharmaceuticals

BlackRock
Vanguard Group
RA Capital Management
Deerfield Management Company
Vanguard Portfolio Management
Vanguard Capital Management
State Street Corporation
TCG Crossover Management
Henderson Group
Perceptive Advisors
Vestal Point Capital
Two Sigma Investments
Geode Capital Management
Kynam Capital Management
Bank of America Corporation

View all funds holding BioCryst Pharmaceuticals